82 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Thursday’s Close
NVS Novartis AG $85.13 $197.65B N/A
Article Searches
Novartis AG (NVS) CEO Vasant Narasimhan on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4319978-novartis-ag-nvs-ceo-vasant-narasimhan-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare Jan 29, 2020 - Novartis AG (NYSE:NVS) Q4 2019 Results Earnings Conference Call January 29, 2020, 08:00 AM ET Company Participants Samir Shah - Global Head of IR Vasant Narasimhan - CEO Harry Kirsch - CFO Marie-Franc
Incyte's Phase III Atopic Dermatitis Study Meets Primary Goal http://www.zacks.com/stock/news/738931/incytes-phase-iii-atopic-dermatitis-study-meets-primary-goal?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-738931 Jan 29, 2020 - Incyte (INCY) posts positive top-line results from late-stage TRuE-AD2 study on ruxolitinib cream to treat adolescent and adult patients with atopic dermatitis. The study achieves its main goal.
Core Laboratories NV (CLB) Q4 2019 Earnings Call Transcript https://www.fool.com/earnings/call-transcripts/2020/01/30/core-laboratories-nv-clb-q4-2019-earnings-call-tra.aspx?source=iedfolrf0000001 Jan 30, 2020 - CLB earnings call for the period ending December 31, 2019.
Top Stock Analyst Reports for Microsoft, Facebook & Novartis http://www.zacks.com/research-daily/742667/top-stock-analyst-reports-for-microsoft-facebook-novartis?cid=CS-ZC-FT-research_daily-742667 Jan 31, 2020 - Top Stock Analyst Reports for Microsoft, Facebook & Novartis
Pharma Stock Roundup: LLY, PFE Q4 Results, JNJ's Coronavirus Vaccine Initiative http://www.zacks.com/stock/news/742655/pharma-stock-roundup-lly-pfe-q4-results-jnjs-coronavirus-vaccine-initiative?cid=CS-ZC-FT-analyst_blog|stock_roundup-742655 Jan 31, 2020 - Lilly (LLY), Pfizer (PFE) and Novartis (NVS) announce Q4 results.
Is a Disappointment in Store for Glaxo's (GSK) Q4 Earnings? http://www.zacks.com/stock/news/746863/is-a-disappointment-in-store-for-glaxos-gsk-q4-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-746863 Feb 03, 2020 - Glaxo's (GSK) Vaccines and Respiratory segments are likely to have driven sales in the fourth quarter.
Ferrari NV (RACE) CEO Louis Camilleri on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4321313-ferrari-nv-race-ceo-louis-camilleri-on-q4-2019-results-earnings-call-transcript?source=feed_sector_transcripts Feb 04, 2020 - Ferrari N.V. (NYSE:RACE) Q4 2019 Earnings Conference Call February 04, 2020, 09:00 AM ET Company Participants Nicoletta Russo - Head IR Louis Camilleri - CEO Antonio Piccon - CFO Conference Call Parti
MELEXIS NV IEPER (MLXSF) CEO Françoise Chombar on Q4 2019 Results - Earnings Call Transcript https://seekingalpha.com/article/4321648-melexis-nv-ieper-mlxsf-ceo-francoise-chombar-on-q4-2019-results-earnings-call-transcript?source=feed_sector_transcripts Feb 05, 2020 - MELEXIS NV IEPER (OTC:MLXSF) Q4 2019 Earnings Conference Call February 05, 2020 4:30 AM ET Company Participants Françoise Chombar – Chief Executive Officer Karen Van Griensven – Chief Financial Office
Roche Reports Disappointing Data on Alzheimer's Disease Drug http://www.zacks.com/stock/news/758962/roche-reports-disappointing-data-on-alzheimers-disease-drug?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-758962 Feb 10, 2020 - Roche's (RHHBY) Alzheimer's disease drug fails to meet primary endpoint in a phase II/III study.
Telenet Group Holding NV 2019 Q4 - Results - Earnings Call Presentation https://seekingalpha.com/article/4323385-telenet-group-holding-nv-2019-q4-results-earnings-call-presentation?source=feed_all_articles Feb 12, 2020 - The following slide deck was published by Telenet Group Holding NV in conjunction with their 2019 Q4 earnings call.

Pages: 123456789

<<<Page 4>